SHANGHAI, Dec. 14, 2021 /PRNewswire/ -- Molecular Data Inc.
("Molecular Data" or the "Company") (Nasdaq: MKD), a leading
technology-driven platform in China's chemical industry, today announced
that the Company has entered an agreement to form a Joint Venture
to build supercomputing clusters in North
America. The new Joint Venture plans to construct two plants
in the USA and start operating on
one plant in the next two months in the initial phase. The Company
expects to add 13MW in the initial phase. The new business line is expected to
generate approximately US$5 million
in revenue and US$4 million in gross
profit.
The Company has made a strategic decision to develop blockchain
technologies to add on to its chemical platform infrastructure
given the rising needs for Digital factories and Smart
manufacturing. This is a critical migration into Industrial
Metaverse from Industrial Internet. Industrial Metaverse can solve
the pain points of enterprises and aid in their digital
transformation."
Dr. Dongliang Chang, Chairman of
Board of Directors of Molecular Data said,"Based on its technical
characteristics, blockchain elements are building blocks for
application scenarios of the Industrial Metaverse. Therefore, we
will continue to develop our blockchain capabilities to further
enhance our competitiveness in the chemical platform and related
businesses."
About Molecular Data Inc.
Molecular Data Inc. is a technology-driven platform in
China's chemical industry,
connecting participants along the chemical value chain through
integrated solutions. The Company delivers e-commerce solutions,
financial solutions, warehousing and logistics solutions, and SaaS
suite that are intended to solve pain points for participants in
the traditional chemical industry. Built upon a comprehensive
knowledge engine and artificial intelligence (AI) capabilities, the
Company's e-commerce solutions are mainly offered through its
online platform, consisting of molbase.com, molbase.cn, Moku Data
WeChat account, Chemical Community APP and other ancillary
platforms.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the U.S.
Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
"will," "expects," "anticipates," "aims," "future," "intends,"
"plans," "believes," "estimates," "confident," "potential,"
"continue" or other similar expressions. Among other things, the
quotations from management in this announcement, as well as the
Company's strategic and operational plans, contain forward-looking
statements. The Company may also make written or oral
forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Statements that are not historical facts, including
but not limited to statements about the Company's beliefs and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties, and a variety
of factors could cause actual results to differ materially from
those contained in any forward-looking statement, including but not
limited to the following: the Company's goals and strategies; the
Company's future business development, results of operations and
financial condition; the expected growth of the chemical market;
the Company's ability to monetize the user base; fluctuations in
general economic and business conditions in China; the potential impact of the COVID-19 to
the Company's business operations and the economy in China and elsewhere generally; and assumptions
underlying or related to any of the foregoing. Further information
regarding these and other risks is included in the Company's
filings with the Securities and Exchange Commission. All
information provided in this press release is as of the date of the
press release, and the Company undertakes no duty to update such
information, except as required under applicable law.
View original
content:https://www.prnewswire.com/news-releases/mkd-sets-its-eyes-on-supercomputing-in-north-america-301444180.html
SOURCE Molecular Data Inc.